Phreesia, Inc. (NYSE:PHR) COO Evan Roberts Sells 16,005 Shares

Phreesia, Inc. (NYSE:PHR - Get Free Report) COO Evan Roberts sold 16,005 shares of the company's stock in a transaction that occurred on Thursday, February 13th. The shares were sold at an average price of $30.00, for a total transaction of $480,150.00. Following the sale, the chief operating officer now directly owns 748,302 shares of the company's stock, valued at approximately $22,449,060. This represents a 2.09 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Evan Roberts also recently made the following trade(s):

• On Tuesday, February 18th, Evan Roberts sold 3,519 shares of Phreesia stock. The stock was sold at an average price of $30.06, for a total transaction of $105,781.14.
• On Monday, January 27th, Evan Roberts sold 10,716 shares of Phreesia stock. The stock was sold at an average price of $27.48, for a total transaction of $294,475.68.
• On Tuesday, January 21st, Evan Roberts sold 12,749 shares of Phreesia stock. The stock was sold at an average price of $27.31, for a total transaction of $348,175.19.
• On Wednesday, January 15th, Evan Roberts sold 1,785 shares of Phreesia stock. The stock was sold at an average price of $26.98, for a total transaction of $48,159.30.
• On Wednesday, January 8th, Evan Roberts sold 2,681 shares of Phreesia stock. The stock was sold at an average price of $27.95, for a total transaction of $74,933.95.
• On Monday, January 6th, Evan Roberts sold 2,873 shares of Phreesia stock. The stock was sold at an average price of $26.61, for a total transaction of $76,450.53.

Phreesia Trading Down 0.9 %

Shares of Phreesia stock traded down $0.27 during trading on Friday, hitting $28.20. The stock had a trading volume of 500,095 shares, compared to its average volume of 364,321. The firm's fifty day simple moving average is $27.29 and its 200-day simple moving average is $23.84. The stock has a market cap of $1.64 billion, a PE ratio of -19.18 and a beta of 0.96. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.74 and a quick ratio of 1.74. Phreesia, Inc. has a 12 month low of $17.07 and a 12 month high of $30.53.

Phreesia (NYSE:PHR - Get Free Report) last released its earnings results on Monday, December 9th. The company reported ($0.25) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.29) by $0.04. The firm had revenue of $106.80 million during the quarter, compared to analyst estimates of $106.33 million. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. The business's revenue was up 16.6% on a year-over-year basis. During the same quarter last year, the business earned ($0.58) EPS. As a group, sell-side analysts expect that Phreesia, Inc. will post -1.1 EPS for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts recently weighed in on the stock. Truist Financial raised their target price on shares of Phreesia from $31.00 to $34.00 and gave the company a "buy" rating in a research note on Wednesday, December 11th. Robert W. Baird cut their target price on shares of Phreesia from $34.00 to $30.00 and set an "outperform" rating for the company in a research note on Wednesday, December 11th. Royal Bank of Canada raised shares of Phreesia from a "sector perform" rating to an "outperform" rating and raised their target price for the company from $24.00 to $32.00 in a research note on Wednesday, January 8th. Needham & Company LLC reaffirmed a "buy" rating and set a $29.00 target price on shares of Phreesia in a research note on Friday, January 10th. Finally, Piper Sandler reaffirmed an "overweight" rating and set a $33.00 target price (up from $31.00) on shares of Phreesia in a research note on Wednesday, January 29th. Thirteen investment analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company has an average rating of "Buy" and a consensus target price of $31.15.

Institutional Investors Weigh In On Phreesia

Several institutional investors have recently made changes to their positions in the company. Invesco Ltd. lifted its holdings in shares of Phreesia by 0.9% in the 4th quarter. Invesco Ltd. now owns 40,249 shares of the company's stock worth $1,013,000 after acquiring an additional 357 shares during the last quarter. NewEdge Advisors LLC lifted its holdings in shares of Phreesia by 12.1% in the 4th quarter. NewEdge Advisors LLC now owns 4,256 shares of the company's stock worth $107,000 after acquiring an additional 459 shares during the last quarter. Johnson Financial Group Inc. increased its stake in Phreesia by 381.3% in the 4th quarter. Johnson Financial Group Inc. now owns 1,131 shares of the company's stock worth $28,000 after buying an additional 896 shares during the period. The Manufacturers Life Insurance Company increased its stake in Phreesia by 3.3% in the 3rd quarter. The Manufacturers Life Insurance Company now owns 27,935 shares of the company's stock worth $637,000 after buying an additional 905 shares during the period. Finally, MetLife Investment Management LLC increased its stake in Phreesia by 3.8% in the 3rd quarter. MetLife Investment Management LLC now owns 30,781 shares of the company's stock worth $701,000 after buying an additional 1,120 shares during the period. Institutional investors own 92.10% of the company's stock.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.